Team:NYMU-Taipei/Project/Enter

From 2013.igem.org

(Difference between revisions)
 
(14 intermediate revisions not shown)
Line 26: Line 26:
<div style="clear:both;"></div>
<div style="clear:both;"></div>
-
====Materials====
+
===Materials===
-
[[Image:NYMU_TAIPEI_alginateacid.png|thumb|200px|right|Structure of alginate polymer. <br>http://en.wikipedia.org/wiki/Alginate]]
+
 
There are many different biomaterials for cell encapsulation. Among those biomaterials, we chose alginate as our encapsulation material for its abundance, excellent biocompatibility and biodegradability properties.
There are many different biomaterials for cell encapsulation. Among those biomaterials, we chose alginate as our encapsulation material for its abundance, excellent biocompatibility and biodegradability properties.
-
<div style="clear:both;"></div>
 
-
====Results of encapsulation====
+
We successfully encapsulated the engineered ''E.coli''( ''E.coli'' with GFP gene), and controlled its size under 0.1mm. Then we tried to transfer the engineered ''E.coli'' into bees midgut by adding some beads into their food.  
-
We successfully encapsulated the engineered ''E.coli''( ''E.coli'' with GFP gene), and controlled its size between 10 to 200nm. Then we tried to transfer the engineered ''E.coli'' into bees midgut by adding some beads into their food. The experiment result indicate that the engineered ''E.coli'' have made into the bees’ midgut successfully.
+
 
-
<div style="clear:both;"></div>
+
{|
-
===Products—''Bee. E.coli''===
+
|-
-
[[Image:NYMU_TAIPEI_product.jpg|thumb|150px|right|The sugar cube with engineered ''E.coli'' in it. ]]
+
! Alginate structure
 +
! The structure of alginate capsule
 +
|-
 +
| [[File:NYMU_alginate1.png.png|thumb|right|300px]]
 +
| [[File:NYMU_alginate_structure1.png|thumb|right|300px]]
 +
|}
 +
 
 +
===CCD-curing pellet===
 +
 
After we proved that microencapsulation of ''E.coli'' could be sent into midgut through bees’ digestion system, we came up with an idea that we can create a drug-like product which is the mixture of sugar and microencapsulation of engineered ''E.coli''. Therefore, we mixed the solution of microencapsulation with sugar cube and dry it. Then, we create the drug pellet which can cure CCD.
After we proved that microencapsulation of ''E.coli'' could be sent into midgut through bees’ digestion system, we came up with an idea that we can create a drug-like product which is the mixture of sugar and microencapsulation of engineered ''E.coli''. Therefore, we mixed the solution of microencapsulation with sugar cube and dry it. Then, we create the drug pellet which can cure CCD.
<div style="clear:both;"></div>
<div style="clear:both;"></div>
Line 145: Line 152:
==Outcome==
==Outcome==
 +
[[Image:NYMU_TAIPEI_product.jpg|right|The sugar cube with engineered ''E.coli'' in it. ]]
We selected MG1655 as the chassis of our circuit, then successfully finding a way which can avoid the threat of immune system and ensure that ''Bee. coli'' won't spread into the environment while transporting ''Bee. coli'' into bees. Besides, once our chassis entered the midguts of bees, it is able to survive and fight against ''Nosema''.
We selected MG1655 as the chassis of our circuit, then successfully finding a way which can avoid the threat of immune system and ensure that ''Bee. coli'' won't spread into the environment while transporting ''Bee. coli'' into bees. Besides, once our chassis entered the midguts of bees, it is able to survive and fight against ''Nosema''.
We mixed the solution of microencapsulation beads with sugar pellet and dried it. That's what we called CCD-curing pellet.
We mixed the solution of microencapsulation beads with sugar pellet and dried it. That's what we called CCD-curing pellet.
-
 
+
<div style="clear:both;"></div>
{{:Team:NYMU-Taipei/Footer}}
{{:Team:NYMU-Taipei/Footer}}
-
pellet
 

Latest revision as of 17:46, 27 October 2013

National Yang Ming University


Contents

Entering of Bee. coli

Introduction

In this part, the main purpose is to send Bee. coli into bees and make sure it can survive in the midguts. We chose Escherichia coli MG1655 as the chassis of our circuit, then incorporating MG1655 into alginate microcapsules, and fed bees with sugar water containing microencapsulation beads. According to our experiment, this method could successfully transport the engineered Bee. coli into the bees’ midgut.

Background

Why encapsulation?

The host immune system imposes a great threat on our engineered E.coli. Besides we have to transported our engineered E.coli in the bees through bees’ digest system, which may contain many kinds of digestive solution with variable pH value that do harm to our engineered E.coli.

To solve this problem, we have to cover the E.coli with a membrane. And encapsulation is an easy way to reach the goal. Comparing to other approaches, cell encapsulation is easy to manipulate. So we choose cell encapsulation as the approach to cover the E.coli.

Materials

There are many different biomaterials for cell encapsulation. Among those biomaterials, we chose alginate as our encapsulation material for its abundance, excellent biocompatibility and biodegradability properties.

We successfully encapsulated the engineered E.coli( E.coli with GFP gene), and controlled its size under 0.1mm. Then we tried to transfer the engineered E.coli into bees midgut by adding some beads into their food.

Alginate structure The structure of alginate capsule
NYMU alginate1.png.png
NYMU alginate structure1.png

CCD-curing pellet

After we proved that microencapsulation of E.coli could be sent into midgut through bees’ digestion system, we came up with an idea that we can create a drug-like product which is the mixture of sugar and microencapsulation of engineered E.coli. Therefore, we mixed the solution of microencapsulation with sugar cube and dry it. Then, we create the drug pellet which can cure CCD.


Experiments

Comparison of DH5 alpha and MG1655

We transformed red fluorescent protein into MG1655 and DH5 alpha, and then spread these bacteria onto the LB agar plates. After cultured at 37 degree for 16 hours, we calculated the number of colonies and found the transformation efficiency of DH5 alpha is about 100-fold higher than MG1655.

DH5 alpha MG1655
NYMU Transformation comparison-DH5 alpha .jpg
NYMU Transformation comparison-MG1655.jpg

Oxidative stress tolerance of MG1655

To know the oxidative stress tolerance of MG1655, we tested the susceptibility to H2O2 in MG1655.

Survival test

  1. MG1655 cells were cultivated at 37 ˚C until the optical density (OD600) of the medium became 0.4~0.6
  2. The culture was equally dispensed (1 ml each) into sample tubes, and then cells were treated with various concentrations of H2O2 (final concentrations were as follows: 10μM, 50μM, 100μM, 500μM, 1 mM, 5mM, 10mM, 50mM and 100mM) at 37 ˚C for 60 min
  3. Testing the OD of each samples
  4. Doing serial dilution on samples by mixing fresh LB medium with samples
  5. 20μl of the diluted sample was spread out on a LB plate (amp-) and incubated at 37 ˚C (overnight)

Results and discussion

Susceptibility to H2O2 in MG1655 shown in OD Susceptibility to H2O2 in MG1655 shown in colonies
NYMU OD of MG1655 to H2O2.png.png
NYMU Colonies of MG1655 to H2O2.png

From these charts, the oxidative stress tolerance of MG1655 is higher than 5mM, and epithelial cells is only 0.05mM. In the other words, the tolerance to ROS of MG1655 is over 100-fold higher than cells in midgut. Therefore, MG1655 will survive even in the stress environment in the midgut.

Treated with 100mM H2O2 diluted 104times Treated with 50mM H2O2 diluted 104times Treated with 10mM H2O2 diluted 105times Treated with 5mM H2O2 diluted 105times Treated with 1mM H2O2 diluted 106times
NYMU Treated with 100mM.jpg
NYMU Treated with 50mM.jpg
NYMU Treated with 10mM.jpg
NYMU Treated with 5mM.jpg
NYMU Treated with 1mM.jpg
Treated with 500μM H2O2 diluted 106times Treated with 100μM H2O2 diluted 107times Treated with 50μM H2O2 diluted 107times Treated with 10μM H2O2 diluted 107times Treated with 0μM H2O2 diluted 107times
NYMU Treated with 500μM.jpg
NYMU Treated with 100μM.jpg
NYMU Treated with 50μM.jpg
NYMU Treated with 10μM.jpg
NYMU Treated with 0μM.jpg

Comparison table of MG1655 and DH5 alpha

Comparison MG1655 DH5 alpha
Strain K12 K12
Genotype F-, lambda-, rph-1 -fhuA2 lac(del)U169 phoA glnV44 Φ80' lacZ(del)M15 gyrA96 recA1 relA1 endA1
Characteristics Similar to wild-type Designed for transformation
Transformation efficiency >1x108cfu/μg >1x106cfu/μg
Oxidative stress tolerance <0.1mM >5mM


Entering the bees' midgut

Getting into bees’ midgut

left up: bees' gut , right up: no fluorescent light, left down: bees' gut after intaking Bee. coli, right down: lots of fluorescent signal

We dropped some solution with microencapsulation of E.coli on the sugar cube. After three days, we pulled out bees’ midgut and see if there was engineered E.coli. We also pulled out bees’ midgut from those who did not intake engineered E.coli and compared the result.

Products

left up: bees' gut , right up: no fluorescent light, left down: bees' gut after intaking our product, right down: lots of fluorescent signal

After the engineered E.coli was made into our pellet product, we wondered that if the engineered E.coli still work. We dissolved our pellet product in sugar water and fed our bees. After 3 days, we pulled out bees’ midgut and see if there was any engineered E.coli. The result show that there were still engineered E.coli, that was our product really work.

Outcome

The sugar cube with engineered E.coli in it.

We selected MG1655 as the chassis of our circuit, then successfully finding a way which can avoid the threat of immune system and ensure that Bee. coli won't spread into the environment while transporting Bee. coli into bees. Besides, once our chassis entered the midguts of bees, it is able to survive and fight against Nosema. We mixed the solution of microencapsulation beads with sugar pellet and dried it. That's what we called CCD-curing pellet.